Cha Hospital Opens Asia's Largest AI Specialized Global Infertility Center in Magok, Seoul
Nov 12, 2025
Cha Hospital, which specializes in infertility treatment, opened 'AI Specialized Global Infertility Center' in Magok District, Seoul.
Located near Magoknaru Station, Magok Cha Hospital's fertility center is 6,611 square meters (about 2,000 pyeong) and is Asia's largest.
It will start full-scale treatment on the 17th of this month with 9 medical rooms, 5 operating rooms, and clean room culture rooms that meet international standards such as AI Nanjabank. Han Se-yeol, the head of Cha Hospital, a leader in K-difficulty that has grown infertility worldwide, and Moon Shin-yong, a former Seoul National University professor who gave birth to the country's first test tube baby, will be treated. For the first time in the industry, it has also recruited AI experts.
Magokcha Hospital plans to implement a future infertility treatment model based on precision medical care by adding AI technology and patient-centered treatment philosophy to the vast reproductive medicine data that Cha Hospital has accumulated for 65 years. ▲ AI embryo classification ▲ automatic analysis of germ cells (suspended and ovary) ▲ prediction of implantability ▲ PGT (pre-implantation genetic test) auxiliary analysis ▲ AI chatbot will be used to introduce precision infertility treatment. In addition, AI technology will be applied to the egg freezing field to accurately predict the quality and freezing time of the egg, and predict and analyze the possibility of embryo formation after thawing to support the preservation of women's fertility. In addition, infertility researchers with more than 20 years of experience are responsible for high pregnancy success rates along with medical staff.
K- Director Han Se-yeol, who has been leading infertility, and Professor Moon Shin-yong are also drawing attention. Han Se-yeol, the director of infertility at Cha Hospital, who was appointed as the head of Magokcha Hospital, is an authority in the fields of pregnancy of elderly mothers, storage of germ cells, preservation of fertility, laparoscopic and cervical surgery, and IVM (in vitro culture of immature eggs). Cha Kwang-ryul Cha Hospital and Cha Bio in 1998The group's global research team contributed to the development of the world's first vitrified egg freezing method. In 2012, the 57-year-old mother, the oldest in Korea, succeeded in twin pregnancy through an in vitro baby procedure, and has helped more than 10,000 infertile couples conceive for 37 years. In addition, Moon Shin-yong, a former professor at Seoul National University Hospital who gave birth to Korea's first in vitro baby, also joined as an honorary chairman. Professor Moon Shin-yong has more than 30 years of research and clinical experience in reproductive medicine and is an authority who has greatly contributed to the development of infertility treatment technology at home and abroad.
Han Se-yeol, director of Magokcha Hospital, explained, "In an era when science and technology advance and artificial intelligence lead the change in medical care, Magokcha Hospital will provide more scientific and precise personalized treatment services by combining cutting-edge technologies.". "If Jamsil Cha Hospital opened the first research center specializing in immature egg culture (IVM) in Korea last year to suggest the possibility of personalized in vitro procedures, this Magokcha Hospital will rewrite the paradigm of infertility treatment based on AI technology." In addition, "Airport access is excellent, and Magok will be made a mecca of K-difficulties in connection with nearby hotels." he expressed his ambition.
Magokcha Hospital plans to join a large number of talented medical staff such as Yang Nuri, Yeom Sun-hyung, Lim Jung-mi and Kim Ji-eun of Seoul Station Center, and Jeong Ja-yeon of Bundang Cha Hospital to provide customized treatment for patients who are having difficulty getting pregnant.
Honorary Director Moon Shin-yong "Cha Hospital, one of the world's top three fertility centers, has established itself as a leading global provider of infertility reproductive medicine with achievements such as the birth of the first test tube baby (1986), successful pregnancy and childbirth of immature eggs (1989), the development of the world's first vitrified egg freezing method (1998), and the establishment of the world's first egg bank (1999)""We hope that the Magok Infertility Center will establish itself as the birthplace of global infertility treatment, providing infertile couples with the joy of pregnancy, and further contributing to raising the fertility rate in Korea. "
Yoon Seok-hwan, managing director of Cha Biotech, who will be in charge of overall AI at Magokcha Hospital, said "We will do our best to present a new paradigm for infertility treatment by using AI to increase customer service across treatment and convenience.", he explained.
Meanwhile, Magokcha Hospital will officially introduce the first 'KareChat' service specialized for infertility centers in Korea with its opening. CareChat is a smart healthcare platform that allows users to easily use hospital appointments, schedule changes, and infertility-related educational content based on KakaoTalk without installing a separate application. Through this, infertile customers can easily check the information they need before visiting the hospital and conveniently manage customized infertility treatment schedules.
Located near Magoknaru Station, Magok Cha Hospital's fertility center is 6,611 square meters (about 2,000 pyeong) and is Asia's largest.
It will start full-scale treatment on the 17th of this month with 9 medical rooms, 5 operating rooms, and clean room culture rooms that meet international standards such as AI Nanjabank. Han Se-yeol, the head of Cha Hospital, a leader in K-difficulty that has grown infertility worldwide, and Moon Shin-yong, a former Seoul National University professor who gave birth to the country's first test tube baby, will be treated. For the first time in the industry, it has also recruited AI experts.
Magokcha Hospital plans to implement a future infertility treatment model based on precision medical care by adding AI technology and patient-centered treatment philosophy to the vast reproductive medicine data that Cha Hospital has accumulated for 65 years. ▲ AI embryo classification ▲ automatic analysis of germ cells (suspended and ovary) ▲ prediction of implantability ▲ PGT (pre-implantation genetic test) auxiliary analysis ▲ AI chatbot will be used to introduce precision infertility treatment. In addition, AI technology will be applied to the egg freezing field to accurately predict the quality and freezing time of the egg, and predict and analyze the possibility of embryo formation after thawing to support the preservation of women's fertility. In addition, infertility researchers with more than 20 years of experience are responsible for high pregnancy success rates along with medical staff.
K- Director Han Se-yeol, who has been leading infertility, and Professor Moon Shin-yong are also drawing attention. Han Se-yeol, the director of infertility at Cha Hospital, who was appointed as the head of Magokcha Hospital, is an authority in the fields of pregnancy of elderly mothers, storage of germ cells, preservation of fertility, laparoscopic and cervical surgery, and IVM (in vitro culture of immature eggs). Cha Kwang-ryul Cha Hospital and Cha Bio in 1998The group's global research team contributed to the development of the world's first vitrified egg freezing method. In 2012, the 57-year-old mother, the oldest in Korea, succeeded in twin pregnancy through an in vitro baby procedure, and has helped more than 10,000 infertile couples conceive for 37 years. In addition, Moon Shin-yong, a former professor at Seoul National University Hospital who gave birth to Korea's first in vitro baby, also joined as an honorary chairman. Professor Moon Shin-yong has more than 30 years of research and clinical experience in reproductive medicine and is an authority who has greatly contributed to the development of infertility treatment technology at home and abroad.
Han Se-yeol, director of Magokcha Hospital, explained, "In an era when science and technology advance and artificial intelligence lead the change in medical care, Magokcha Hospital will provide more scientific and precise personalized treatment services by combining cutting-edge technologies.". "If Jamsil Cha Hospital opened the first research center specializing in immature egg culture (IVM) in Korea last year to suggest the possibility of personalized in vitro procedures, this Magokcha Hospital will rewrite the paradigm of infertility treatment based on AI technology." In addition, "Airport access is excellent, and Magok will be made a mecca of K-difficulties in connection with nearby hotels." he expressed his ambition.
Magokcha Hospital plans to join a large number of talented medical staff such as Yang Nuri, Yeom Sun-hyung, Lim Jung-mi and Kim Ji-eun of Seoul Station Center, and Jeong Ja-yeon of Bundang Cha Hospital to provide customized treatment for patients who are having difficulty getting pregnant.
Honorary Director Moon Shin-yong "Cha Hospital, one of the world's top three fertility centers, has established itself as a leading global provider of infertility reproductive medicine with achievements such as the birth of the first test tube baby (1986), successful pregnancy and childbirth of immature eggs (1989), the development of the world's first vitrified egg freezing method (1998), and the establishment of the world's first egg bank (1999)""We hope that the Magok Infertility Center will establish itself as the birthplace of global infertility treatment, providing infertile couples with the joy of pregnancy, and further contributing to raising the fertility rate in Korea. "
Yoon Seok-hwan, managing director of Cha Biotech, who will be in charge of overall AI at Magokcha Hospital, said "We will do our best to present a new paradigm for infertility treatment by using AI to increase customer service across treatment and convenience.", he explained.
Meanwhile, Magokcha Hospital will officially introduce the first 'KareChat' service specialized for infertility centers in Korea with its opening. CareChat is a smart healthcare platform that allows users to easily use hospital appointments, schedule changes, and infertility-related educational content based on KakaoTalk without installing a separate application. Through this, infertile customers can easily check the information they need before visiting the hospital and conveniently manage customized infertility treatment schedules.
|
This article was translated by Naver AI translator.
